EPRX - Total Utang marang Modal Eupraxia Pharmaceuticals Inc.

Logo perusahaan publik Eupraxia Pharmaceuticals, Inc. (EPRX)

This price chart illustrating value trends demonstrates the financial resilience of Eupraxia Pharmaceuticals (EPRX), which is developing within an autonomous product cycle, transforming the company into a defensive asset. Effective management ensures transparency in drug delivery system trials and skillfully navigates FDA certification stages. Simultaneously, the business is implementing ESG principles by minimizing laboratory waste and utilizing eco-friendly packaging, while the separate_debt_total_eq metric stands at 0.01.

EPRX: Total Utang marang Modal Eupraxia Pharma 06.04.2024 - 31.10.2026

Rincian analitis perusahaan Eupraxia Pharmaceuticals

- rega lan prakiraan konsensus rega:
Bagan rega Eupraxia Pharmaceuticals, Inc.|EPRX - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Eupraxia Pharmaceuticals|EPRX - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Eupraxia Pharmaceuticals|EPRX - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku eupraxiapharma.com|EPRX - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Eupraxia Pharmaceuticals|EPRX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Eupraxia Pharmaceuticals, Inc.|EPRX - Gunggung utang perusahaan|Utang marang nilai buku Eupraxia Pharmaceuticals|EPRX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Eupraxia Pharmaceuticals|Indikator likuiditas cepet eupraxiapharma.com
- informasi bathi lan kelipatan valuasi:
EPRX - Bathi sawise mbayar pajeg
Analisis dhasar perusahaan:Eupraxia Pharmaceuticals
Barang utama Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals (EPRX) advances biopharmaceutical developments by integrating rigorous ESG standards and environmental safety into its operational processes. Analyzing the debt-to-equity ratio dynamics allows for an assessment of the company's financial stability. This metric compares total liabilities against market capitalization to determine the business's degree of reliance on borrowed capital. A declining ratio confirms a strengthening balance sheet or an increase in asset value. For investors, this serves as a key indicator of the enterprise's long-term solvency.

Analisis pesaing Eupraxia Pharmaceuticals

Utang marang Ekuitas Haleon|Kenvue Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal VRNA|MENS (Jyong Bio) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|Total Utang marang Modal amneal.com AMRX|PRGO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Galapagos Corp|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com|Rasio Total Utang marang Ekuitas AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas ARS Pharma SPRY|Theravance Corp (TBPH) - Utang marang Modal|AQST: Rasio Total Utang marang Ekuitas|scPharmaceuticals Inc. - Utang Agregat marang Modal|TECX: Total Utang marang Modal|Tonix Pharma - Rasio Kabeh Utang marang Dana Pribadi|SXTC (SXT Pharmaceuticals) - Total Utang marang Modal|Utang marang Modal BioHarvest Sciences Inc BHST|Utang marang Ekuitas eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ENTX (Entera Bio)|MindWalk Holdings, Inc. (HYFT) - Utang marang Modal|ABVC: Rasio Total Utang marang Ekuitas|CPIX - Total Utang marang Modal|Quantum BioPharma Ltd (QNTM) - Utang marang Ekuitas|Utang Agregat marang Ekuitas FGEN (fibrogen.com)|Utang marang Ekuitas Telomir Pharmaceuticals, Inc.|RANI: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal SNYR|Total Utang marang Modal rallybio.com (RLYB)|Lexaria Bioscience Corp. - Rasio Total Utang marang Ekuitas|PULM: Rasio Utang marang Ekuitas|Pheton - Total Utang marang Modal|Koefisien Total Utang marang Modal Aptorum Group Limited APM|LYRA: Total Utang marang Modal|Impact BioMedical, Inc. (IBO) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas TNFA|YCBD: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas PainReform (PRFX)|CYTO: Utang Agregat marang Ekuitas|Total Utang marang Modal LIPO (Lipella)|Rasio Kabeh Utang marang Dana Pribadi OPTN|Pieris Pharmaceuticals - Total Utang marang Modal|PROC - Total Utang marang Modal|Petros Pharmaceuticals, Inc. (PTPI) - Utang marang Ekuitas|Qilian International Holding Group - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas ACELYRIN, Inc.|Rasio Total Utang marang Ekuitas TFF Pharmaceuticals, Inc (TFFP)